About Drew Ben-Aharon Drew Ben-Aharon has over 25 years of experience in executive sales, corporate operations and human capital management. He currently serves as Chief Growth Officer and Product Development for Great Speech and is responsible for all enterprise and health plan sales in the United States. As a consultant and
General
Industry News: Volume 3, Issue 1
Why pediatricians are worried about the end of the federal COVID emergency By Sebastian Martinez Valdivia npr.org – Kathreen Friend is a pediatric registered nurse based in Doniphan, Missouri — a small town of about 1,800 near the Arkansas border. As the lone pediatric specialist in Ripley County, she stays extremely busy. She works
Volume 2, Issue 3: Sharon Kleefield, Ph.D., Healthcare Standards Institute, Discusses Quality of Care and Standardization of Healthcare System Benchmarking
Dear Colleagues, Good news for the medical travel community, domestic and international: Medical Travel & Digital Health News (MTDHN) has been accepted as the sponsor of the first “Medical Travel Month” – January 2022 – in the Society for Healthcare Marketing and Development, American Hospital Association’s “2022 Calendar of Health Observances
Spotlight Interview: Sharon Kleefield, Ph.D., Healthcare Standards Institute
About Sharon Kleefield, Ph.D. Retired faculty, Harvard Medical School (HMS), and former Director of Healthcare Quality at Harvard Medical International. Her work has focused on developing and deploying standards in healthcare. Her expertise includes Health Care Management Education and Training programs for clinical staff both at HMS and globally. Prior to
Industry News: Volume 2, Issue 3
Echosens Presents Research at 2021 AASLD Liver Meeting: Early Detection and Monitoring with FibroScan Mitigates Risk of Patients Developing Fibrosis/Cirrhosis PARIS & WALTHAM, Mass.--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan® family of products, is pleased to announce its strong presence at the upcoming American Association for the Study of Liver Diseases
Volume 1, Issue 10: Rajesh Rao, CEO, IndusHealth; David Mair, SVP, Hospital CIMA; and Brad Cook, President, Medical Tours Costa Rica Discuss Costa Rica’s Role in the Medical Travel and Tourism Industry
Dear colleagues, In this issue, we speak with Rajesh Rao, CEO, IndusHealth, David Mair, SVP, Hospital CIMA, and Brad Cook, President, Medical Tours Costa Rica, to discuss Costa Rica’s role in the medical travel and tourism industry and how they’ve adapted to operate in the age of Covid-19. This issue also brings
Volume 1, Issue 5: Ryan Palmer, Ed.D., M.F.A., Principal, Kennedy & Company Education Strategies Discusses Medical Students on Meeting with Patients Virtually via Telehealth
Dear colleagues, We hope you had a safe and wonderful holiday season despite the continued unprecedented circumstances. While the COVID-19 pandemic has halted growth in the medical travel sector, expect the pace to pick up again throughout the new year as the opportunity for vaccines spreads worldwide. If you missed our announcement about
Spotlight Interview: Ryan Palmer, Ed.D., M.F.A., Principal, Kennedy & Company Education Strategies
About Ryan Palmer, Ed.D., M.F.A. Ryan Palmer, Ed.D., M.F.A. is a Principal at Kennedy and Company, a Washington DC based higher education consulting firm.Hehas over 15 years of experience in medical education in both faculty and administrative roles, most recently as an Associate Dean of Medical Education. Dr. Palmer is a
Industry News: Volume 1, Issue 5
Bionic Eyes May Prompt New Wave of Medical Tourism By Farlyn Lucas While most people associate medical tourism with dental work, complex surgeries, or even assisted suicide, Hawaii has added yet another form of treatment to the list: Bionic eyes. It might sound like something out of a science fiction novel, but
Industry News: Volume 10, Issue 25
Johnson & Johnson gears up for 60,000-person COVID-19 vaccine trial, the industry's biggest yet by Eric Sagonowsky fiercepharma.com - With several COVID-19 vaccines already in phase 3 trials and investigators aiming to enroll tens of thousands of participants, Johnson & Johnson is prepping the largest study yet. The drugmaker is planning to enroll a whopping